In addition, further dissecting the mutation data into different cancer subtype groups (such as MSI and non-MSI in colorectal cancer, ER+, HER2+ and TNBC in breast cancer) would be helpful to distinguish distinct mutation profiles and precisely investigate the specific function of hotspot mutations in different cancer subtypes. Here, ERBB2 is linked to cancer.